Voltammetry of irbesartan drug in pharmaceutical formulations and human blood: quantification and pharmacokinetic studies
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Journal of the Brazilian Chemical Society (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532011000200008 |
Resumo: | Cyclic voltammograms of irbesartan at the hanging mercury dropping electrode in the Britton-Robinson buffer of pH values lower than 4.5 exhibited a single 2-electron irreversible cathodic peak corresponding to the reduction-saturation of the C=N double bond of its tetrazolyl moiety. Over the pH range 4.5-5.5, the voltammograms exhibited two irreversible cathodic peaks (1st and 2nd peaks) of lower peak current but of relatively equal heights which were attributed to reduction of the C=N group of the acidic and basic forms of irbesartan, respectively. A validated square-wave adsorptive cathodic stripping voltammetric method was developed for quantification of irbesartan in the bulk form. The developed stripping voltammetric method was successfully applied for quantitation of irbesartan in pharmaceutical formulations and spiked human serum, without the necessity for samples pretreatment and/or time-consuming extraction steps prior to the analysis. Insignificant interferences from its active ingredient "hydrochlorothiazide", excipients, common metal ions and co-administrated drugs were obtained during the analysis. Limits of detection of 9.0x10-10 and 2.1x10-9 mol L-1 and limits of quantitation of 3.0x10-9 and 7.0x10-9 mol L-1 irbesartan in the bulk form and in spiked human serum were achieved, respectively, by the developed stripping voltammetric method. Moreover, pharmacokinetic parameters of irbesartan in plasma of healthy volunteers following an oral administration of a single dose of Aprovel® tablets were also estimated. |
id |
SBQ-2_f81289a176f163ecb2b164ae62a2640c |
---|---|
oai_identifier_str |
oai:scielo:S0103-50532011000200008 |
network_acronym_str |
SBQ-2 |
network_name_str |
Journal of the Brazilian Chemical Society (Online) |
repository_id_str |
|
spelling |
Voltammetry of irbesartan drug in pharmaceutical formulations and human blood: quantification and pharmacokinetic studiesirbesartantabletshuman bloodstripping voltammetrypharmacokineticsCyclic voltammograms of irbesartan at the hanging mercury dropping electrode in the Britton-Robinson buffer of pH values lower than 4.5 exhibited a single 2-electron irreversible cathodic peak corresponding to the reduction-saturation of the C=N double bond of its tetrazolyl moiety. Over the pH range 4.5-5.5, the voltammograms exhibited two irreversible cathodic peaks (1st and 2nd peaks) of lower peak current but of relatively equal heights which were attributed to reduction of the C=N group of the acidic and basic forms of irbesartan, respectively. A validated square-wave adsorptive cathodic stripping voltammetric method was developed for quantification of irbesartan in the bulk form. The developed stripping voltammetric method was successfully applied for quantitation of irbesartan in pharmaceutical formulations and spiked human serum, without the necessity for samples pretreatment and/or time-consuming extraction steps prior to the analysis. Insignificant interferences from its active ingredient "hydrochlorothiazide", excipients, common metal ions and co-administrated drugs were obtained during the analysis. Limits of detection of 9.0x10-10 and 2.1x10-9 mol L-1 and limits of quantitation of 3.0x10-9 and 7.0x10-9 mol L-1 irbesartan in the bulk form and in spiked human serum were achieved, respectively, by the developed stripping voltammetric method. Moreover, pharmacokinetic parameters of irbesartan in plasma of healthy volunteers following an oral administration of a single dose of Aprovel® tablets were also estimated.Sociedade Brasileira de Química2011-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532011000200008Journal of the Brazilian Chemical Society v.22 n.2 2011reponame:Journal of the Brazilian Chemical Society (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.1590/S0103-50532011000200008info:eu-repo/semantics/openAccessEl-Desoky,Hanaa SGhoneim,Mohamed MHabazy,Allia. Deng2011-02-14T00:00:00Zoai:scielo:S0103-50532011000200008Revistahttp://jbcs.sbq.org.brONGhttps://old.scielo.br/oai/scielo-oai.php||office@jbcs.sbq.org.br1678-47900103-5053opendoar:2011-02-14T00:00Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ)false |
dc.title.none.fl_str_mv |
Voltammetry of irbesartan drug in pharmaceutical formulations and human blood: quantification and pharmacokinetic studies |
title |
Voltammetry of irbesartan drug in pharmaceutical formulations and human blood: quantification and pharmacokinetic studies |
spellingShingle |
Voltammetry of irbesartan drug in pharmaceutical formulations and human blood: quantification and pharmacokinetic studies El-Desoky,Hanaa S irbesartan tablets human blood stripping voltammetry pharmacokinetics |
title_short |
Voltammetry of irbesartan drug in pharmaceutical formulations and human blood: quantification and pharmacokinetic studies |
title_full |
Voltammetry of irbesartan drug in pharmaceutical formulations and human blood: quantification and pharmacokinetic studies |
title_fullStr |
Voltammetry of irbesartan drug in pharmaceutical formulations and human blood: quantification and pharmacokinetic studies |
title_full_unstemmed |
Voltammetry of irbesartan drug in pharmaceutical formulations and human blood: quantification and pharmacokinetic studies |
title_sort |
Voltammetry of irbesartan drug in pharmaceutical formulations and human blood: quantification and pharmacokinetic studies |
author |
El-Desoky,Hanaa S |
author_facet |
El-Desoky,Hanaa S Ghoneim,Mohamed M Habazy,Allia. D |
author_role |
author |
author2 |
Ghoneim,Mohamed M Habazy,Allia. D |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
El-Desoky,Hanaa S Ghoneim,Mohamed M Habazy,Allia. D |
dc.subject.por.fl_str_mv |
irbesartan tablets human blood stripping voltammetry pharmacokinetics |
topic |
irbesartan tablets human blood stripping voltammetry pharmacokinetics |
description |
Cyclic voltammograms of irbesartan at the hanging mercury dropping electrode in the Britton-Robinson buffer of pH values lower than 4.5 exhibited a single 2-electron irreversible cathodic peak corresponding to the reduction-saturation of the C=N double bond of its tetrazolyl moiety. Over the pH range 4.5-5.5, the voltammograms exhibited two irreversible cathodic peaks (1st and 2nd peaks) of lower peak current but of relatively equal heights which were attributed to reduction of the C=N group of the acidic and basic forms of irbesartan, respectively. A validated square-wave adsorptive cathodic stripping voltammetric method was developed for quantification of irbesartan in the bulk form. The developed stripping voltammetric method was successfully applied for quantitation of irbesartan in pharmaceutical formulations and spiked human serum, without the necessity for samples pretreatment and/or time-consuming extraction steps prior to the analysis. Insignificant interferences from its active ingredient "hydrochlorothiazide", excipients, common metal ions and co-administrated drugs were obtained during the analysis. Limits of detection of 9.0x10-10 and 2.1x10-9 mol L-1 and limits of quantitation of 3.0x10-9 and 7.0x10-9 mol L-1 irbesartan in the bulk form and in spiked human serum were achieved, respectively, by the developed stripping voltammetric method. Moreover, pharmacokinetic parameters of irbesartan in plasma of healthy volunteers following an oral administration of a single dose of Aprovel® tablets were also estimated. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-02-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532011000200008 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532011000200008 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0103-50532011000200008 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Química |
publisher.none.fl_str_mv |
Sociedade Brasileira de Química |
dc.source.none.fl_str_mv |
Journal of the Brazilian Chemical Society v.22 n.2 2011 reponame:Journal of the Brazilian Chemical Society (Online) instname:Sociedade Brasileira de Química (SBQ) instacron:SBQ |
instname_str |
Sociedade Brasileira de Química (SBQ) |
instacron_str |
SBQ |
institution |
SBQ |
reponame_str |
Journal of the Brazilian Chemical Society (Online) |
collection |
Journal of the Brazilian Chemical Society (Online) |
repository.name.fl_str_mv |
Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ) |
repository.mail.fl_str_mv |
||office@jbcs.sbq.org.br |
_version_ |
1750318171891433472 |